Blackrock Neurotech is a neurotechnology company that develops advanced brain-computer interface technologies to improve the lives of people with paralysis and other neurological disorders. The company emphasizes a powerful neurotech platform used by researchers and clinicians worldwide, with a history of clinical use and public demonstrations of brain-controlled capabilities. Its solutions are deployed across hundreds of research labs and institutions, highlighting its global reach and impact in neuroengineering and neural interfaces.
No recent news for this company.
No recent deals for this company.